clinical trial

November 12, 2015November 12, 2015

Fibromyalgia Patients Show Sleep Improvements in Tonmya Study

News

Tonix Pharmaceuticals Holding Corp., a company dedicated to the invention and development of next-generation products for fibromyalgia, episodic tension-type headache, and post-traumatic stress disorder (PTSD), recently presented additional data from ... Read more

October 28, 2015October 28, 2015

FDA Approves BELBUCA Buccal Film for Chronic Pain

News

Raleigh, North Carolina based BioDelivery Sciences International, Inc. (BDSI), a specialty pharmaceutical company with a focus in the areas of pain management and addiction medicine, and its partner Endo Pharmaceuticals ... Read more

August 11, 2015August 11, 2015

Tonix Pharmaceuticals Clinical Trials Underway Investigating New Drugs For Fibromyalgia, PTSD, and Tension Headache

News

Clinical-stage pharmaceutical company Tonix Pharmaceuticals Holding Corp. in conjunction with announcing its second quarter 2015 financial results, reports progress in developing next-generation medicines for treating fibromyalgia, post-traumatic stress disorder (PTSD), ... Read more

June 29, 2015June 29, 2015

Milnacipran May Benefit Juvenile Fibromyalgia Patients

News

Fibromyalgia generally affects adult women. However, juvenile fibromyalgia (JFM) is a disorder that affects up to 6% of children and adolescent patients. More girls than boys are affected by JFM, ... Read more

May 14, 2015May 14, 2015

Tonix Pharmaceuticals Launches Phase 3 Clinical Trial To Evaluate Experimental Fibromyalgia Therapy

News

Tonix Pharmaceuticals Holding Corp. recently announced the beginning of a Phase 3 clinical trial for its product TNX-102 SL (cyclobenzaprine HCl sublingual tablet, 2.8 mg) for the treatment of fibromyalgia. ... Read more

February 19, 2015February 20, 2015

Low Frequency Sound Simulation Reduces Fibromyalgia Symptoms, Study Shows

News

A study published by a team of investigators at the University of Toronto’s Music and Health Research Collaboratory and the Wilfred Laurier University in Waterloo, Ontario presented evidence that the ... Read more

February 5, 2015February 5, 2015

Daiichi Sankyo Launches Enrollment for Clinical Testing in Neuropathic Pain, Neuralgia and Fibromyalgia

News

Daiichi Sankyo Company Ltd., the second largest pharmaceutical company in Japan, has just opened patient enrollment for a large-scale, international clinical research program, designed to determine the safety and efficacy ... Read more